Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia.

MLA

Iruretagoyena, Barbara, et al. “Predictors of Clozapine Discontinuation at 2 years in Treatment-Resistant Schizophrenia.” Schizophrenia Research, vol. 235, Sept. 2021, pp. 102–08. EBSCOhost, https://doi.org/10.1016/j.schres.2021.07.024.

APA

Iruretagoyena, B., Castañeda, C. P., Mena, C., Diaz, C., Nachar, R., Ramirez-Mahaluf, J. P., González-Valderrama, A., Undurraga, J., Maccabe, J. H., & Crossley, N. A. (2021). Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia. Schizophrenia Research, 235, 102–108. https://doi.org/10.1016/j.schres.2021.07.024

Chicago

Iruretagoyena, Barbara, Carmen Paz Castañeda, Cristian Mena, Camila Diaz, Ruben Nachar, Juan Pablo Ramirez-Mahaluf, Alfonso González-Valderrama, Juan Undurraga, James H Maccabe, and Nicolas A Crossley. 2021. “Predictors of Clozapine Discontinuation at 2 years in Treatment-Resistant Schizophrenia.” Schizophrenia Research 235 (September): 102–8. doi:10.1016/j.schres.2021.07.024.